Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
The aim was to assess the possibility of optimizing the costs of drugs for cancer patients in a subject of the Russian Federation considering the expiration of patent protection period.Materials and methods. The possibility of optimizing the costs of antitumor drugs was studied using a model of a hy...
Main Authors: | A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2020-02-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/320 |
Similar Items
-
Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
by: F. V. Gorkavenko, et al.
Published: (2019-07-01) -
Biosimilars in oncology: characteristics and insights
by: Stefano Cascinu
Published: (2013-06-01) -
Generics and the specific features of their regulation
by: E. A. Ushkalova, et al.
Published: (2016-11-01) -
Generics and biosimilars in oncology
by: I. A. Gopienko, et al.
Published: (2020-04-01) -
ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS
by: M. V. Sura, et al.
Published: (2015-05-01)